Director Lang James Paul bought OptimizeRx Corp ($OPRX) shares on the open market once in the last 365 days, for a total of $2.4 million. His most recent purchase occurred on March 14, 2025. These buys rank 272nd among 4,983 insiders in our database by purchase value, above the average of $1.5 million across about 3 transactions per insider. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | BIOVIE INC. | $BIVI | Lang James Paul | Director | A | Stock Option (right to buy) | 330500 | $0.00 | 330,500.0000 | 7,920,795 | 9999.99% | 4.17% |
| Jan. 5, 2026 | BIOVIE INC. | $BIVI | Lang James Paul | Director | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 7,920,795 | 9999.99% | 1.14% |
| Jan. 2, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Lang James Paul | Director | A | Restricted Stock Units | 889 | $0.00 | 889.0000 | 123,904,000 | 9999.99% | 0.00% |
| Jan. 2, 2026 | HALOZYME THERAPEUTICS, INC. | $HALO | Lang James Paul | Director | A | Option to Purchase Common Stock | 1342 | $0.00 | 1,342.0000 | 123,904,000 | 9999.99% | 0.00% |
| June 11, 2025 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | A | Common Stock | 9868 | $0.00 | 399,320.0000 | 20,234,186 | 2.53% | 0.05% |
| March 14, 2025 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | P | Common Stock | 321408 | $7.60 | 389,452.0000 | 20,194,697 | 472.35% | 1.59% |
| Nov. 20, 2024 | BIOVIE INC. | $BIVI | Lang James Paul | Director | A | Stock Option (right to buy) | 61600 | $0.00 | 61,600.0000 | 639,836 | 9999.99% | 9.63% |
| Dec. 20, 2024 | BIOVIE INC. | $BIVI | Lang James Paul | Director | A | Stock Option (right to buy) | 22690 | $0.00 | 22,690.0000 | 639,836 | 9999.99% | 3.55% |
| June 5, 2024 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | M | Restricted Stock Units | 10061 | $0.00 | 0.0000 | 19,921,879 | 100.00% | 0.05% |
| June 7, 2024 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | A | Common Stock | 13286 | $0.00 | 68,044.0000 | 19,921,879 | 24.26% | 0.07% |
| June 5, 2024 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | M | Common Stock | 10061 | $0.00 | 54,758.0000 | 19,921,879 | 22.51% | 0.05% |
| June 7, 2023 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | M | Common Stock | 4637 | $0.00 | 44,697.0000 | 0 | 11.58% | 0.00% |
| June 7, 2023 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | M | Restricted Stock Units | 4637 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2023 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | A | Restricted Stock Units | 10061 | $0.00 | 10,061.0000 | 0 | 9999.99% | 0.00% |
| March 30, 2023 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | M | Restricted Stock Units | 657 | $0.00 | 657.0000 | 0 | 50.00% | 0.00% |
| March 30, 2023 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | M | Common Stock | 657 | $0.00 | 40,060.0000 | 0 | 1.67% | 0.00% |
| Dec. 30, 2022 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | M | Restricted Stock Units | 409 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 30, 2022 | OptimizeRx Corp | $OPRX | Lang James Paul | Director | M | Common Stock | 409 | $0.00 | 39,403.0000 | 0 | 1.05% | 0.00% |